Arena (ARNA) Snubs Downgrade, Now Higher on the Session
Tweet Send to a Friend
Up)
Arena Pharmaceuticals (Nasdaq: ARNA) shares are moving higher as sentiment returns to the pharma ahead of its PDUFA for lorcaserin.
After starting a couple of percentage points lower Monday on a downgrade at BMO Capital, shares are now about 1.5 percent higher.
Volatility is modest, up from 1 percent to 3 percent from last Friday's close and about at par with its trailing historical measure. Volume is solid on the move as well, with about 8 million shares traded early.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
After starting a couple of percentage points lower Monday on a downgrade at BMO Capital, shares are now about 1.5 percent higher.
Volatility is modest, up from 1 percent to 3 percent from last Friday's close and about at par with its trailing historical measure. Volume is solid on the move as well, with about 8 million shares traded early.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Fannie Mae, Freddie Mac Surge as Seriously Delinquent Rate Falls Below 3%
- InterOil (IOC) Gives Up Gains
- Tesla Motors (TSLA) Taps New 52-Week High
Create E-mail Alert Related Categories
Insiders' Blog, Momentum MoversRelated Entities
BMO Capital
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
